Skip to content

Medical Abortion Via Telemedicine for Women and Adolescents in Moldova

Medical Abortion Via Telemedicine for Women and Adolescents in Moldova

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT04316325
Enrollment
549
Registered
2020-03-20
Start date
2020-03-20
Completion date
2021-03-31
Last updated
2021-09-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pregnancy

Brief summary

This study evaluates the safety, feasibility, and acceptability of a novel medical abortion via telemedicine service in the Republic of Moldova.

Detailed description

Women and girls in Moldova, especially those in rural areas, must travel to regional medical centers to obtain an abortion from a certified gynecologist. This creates barriers to accessing safe abortion that disproportionately affect poor women and girls, through wage loss due to missed work and accrued costs due to transportation. This innovation is a novel service delivery model that allows self-management of medical abortion (MA) with remote guidance from a provider. After confirming their pregnancy, women seeking MA will receive counseling from a gynecologist via videoconference and will subsequently obtain the necessary medication via mail or at at participating pharmacy with prescription. Follow-up will occur 1 weeks later via phone/videoconference (with referral to a doctor if necessary) to confirm MA success and assess the patient's and provider's satisfaction with the service. We hope to demonstrate the feasibility, effectiveness and acceptability of telemedicine MA services in Moldova so that it can thus be integrated into the national public healthcare system. As a result, this project will serve as a model that could be adapted and implemented in nearby countries within the Eastern Europe and Central Asia region.

Interventions

DRUGMedical abortion

Trained abortion providers will counsel participants about medical abortion via videoconference or telephone, the abortion medications will be sent to the participants via mail or will be accessed at a pharmacy, the provider will follow up one week later with the participants to assess outcomes, and four weeks later the participant will take a pregnancy test to confirm completion of the abortion

Sponsors

Grand Challenges Canada
CollaboratorOTHER
Gynuity Health Projects
CollaboratorOTHER
Reproductive Health Training Center of the Republic of Moldova
Lead SponsorOTHER

Study design

Observational model
CASE_ONLY
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
FEMALE
Age
16 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* 16 years or older * Has an unwanted pregnancy * Confirmed the pregnancy using a test or via ultrasound * Gestational age of 9 weeks or less * Has personally decided to end the pregnancy * Has a device (phone, tablet, or computer) with internet connection, a webcam, and a microphone. * Has immediate access to emergency services * Reports no contraindication to medical abortion

Exclusion criteria

* Under 16 years of age * Does not have an unwanted pregnancy * Did not confirm pregnancy * Gestational age greater than 9 weeks * Does not have a device (phone, tablet, or computer) with internet connection, a webcam, and a microphone * Does not have immediate access to emergency services * Has an intrauterine device * Is allergic to abortion medications (mifepristone or misoprostol) * Has severe anemia or acute porphyria * Has a condition that affects the ability of blood to clot normally * Has hepatic failure or chronic renal disease * Has an ectopic pregnancy * Has heart disease or other cardiovascular problem * Has a condition that requires hormone treatment

Design outcomes

Primary

MeasureTime frameDescription
Successful termination of pregnancy without adverse eventsthrough study completion, around 15 monthsPercentage of study participants that successfully terminate their pregnancy via the telemedicine medical abortion model without experiencing any adverse events.

Secondary

MeasureTime frameDescription
Participant satisfaction with the medical abortion via telemedicine servicethrough study completion, around 15 monthsPercentage of study participants that report being satisfied or very satisfied with the medical abortion via telemedicine service.
Cost savings experienced by study participantsthrough study completion, around 15 monthsPercentage cost savings among study participants receiving medical abortion via telemedicine in comparison with the cost of in-person medical abortion.
Provider satisfactionthrough study completion, around 15 monthsPercentage of medical abortion providers that report being satisfied or very satisfied with the telemedicine service provision process.

Countries

Moldova

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026